Join us while we debunk the myths associated with insertable cardiac monitoring (ICM) in stroke patients. See the latest clinical evidence on patient outcomes, benefits and the cost-effectiveness of Medtronic ICMs for secondary stroke prevention. Learn why insertable cardiac monitoring is critical for your cryptogenic stroke patients and how you can implement a post-stroke monitoring pathway in your practice.
Georgios Tsivgoulis, M.D., PhD, MSc, FESO, FEAN, FAAN
Professor & Chairman of Second Department of Neurology, School of Medicine, National & Kapodistrian University of Athens, "Attikon University Hospital, Athens, Greece
Suneet Mittal, M.D., FACC, FHRS
Director, Electrophysiology, Associate Chief of Cardiology, Medical Director, Snyder AF Center, Director, Cardiac Research Valley Health System Ridgewood, New Jersey
Klaus Witte, M.D., FRCP, FESC, FACC, FHEA, MSc
Chair of Cardiac Device Therapy, Senior Lecturer in Cardiology and Consultant Cardiologist, University Hospital Aachen, RWTH, Aachen, DE and Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, UK
Julie Brewer
President, Cardiovascular Diagnostic and Services Medtronic
Topics Include:
Learn the latest clinical and economic evidence supporting patient outcomes and cost-effectiveness of ICM in cryptogenic stroke patients.
Understand the benefits of monitoring longer with insertable cardiac monitors vs external cardiac monitors
Hear benefits and strategies for implementing an ICM first cardiac monitoring pathway
Wednesday, January 18, 2023
(60 minutes in length)
9:00 a.m. PT | 10:00 a.m. MT
11:00 a.m. CT | 12:00 a.m. ET 6:00 p.m. CET
Neurologists, Electrophysiologists, Cardiologists, Fellows, APPs, Stroke Coordinators and Nurses
Brief Statement for Medtronic LINQ Family Insertable Cardiac Monitor (ICM) System and Remote Monitoring
Indications
The Reveal LINQ ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:
•patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
•patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia
This device has not been tested specifically for pediatric use.
The LINQ II ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in adult patients, and in pediatric patients who are at least 2 years old, in the following cases:
•patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
•patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia
Contraindications
There are no known contraindications for the insertion of the LINQ Family ICMs or their accessories. However, the patient’s particular medical condition may dictate whether or not a subcutaneous, chronically inserted device can be tolerated.
Warnings and Precautions
Patients with a LINQ Family ICM should avoid sources of diathermy, high sources of radiation, electrosurgical cautery, external defibrillation, lithotripsy, therapeutic ultrasound and radiofrequency ablation to avoid electrical reset of the device, and/or inappropriate sensing as described in the Medical procedure and EMI Warnings, Precautions and Guidance Manual. MRI scans should be performed only in a specified MR environment under specified conditions as described in the LINQ II or Reveal LINQ ICM MRI Technical Manual.
Wireless accessories available for use with a LINQ Family ICM may experience connectivity or performance issues. See product manuals for details and troubleshooting instructions.
Potential Adverse Events
Potential adverse events from the LINQ Family ICM include, but are not limited to, device rejection phenomena (including local tissue reaction), device migration, infection, and erosion through the skin.
There are no known adverse events associated with the use of any LINQ Family ICM wireless accessories.
See the device manuals for detailed information regarding the implant procedure, indications / intended use, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at (800) 328-2518 (Technical Services),
Caution: Federal law (USA) restricts prescription devices to sale by or on the order of a physician.
The information shared at this event may include Medtronic confidential business information and personal data, including the identity of participants, that is subject to protection under applicable privacy laws and regulations. For these reasons, neither audio recording of this call nor screenshots, photos or videos of the content are permitted, except by the organizers. Please note that your log-in/ID/Name may be seen by others. By registering to participate in this event, you agree to keep Medtronic business information confidential and you consent to the disclosure and use of your log-in/ID/Name and to audio and/or video recording of this event by Medtronic for use at its discretion. Medtronic will comply with applicable privacy laws and regulations and its data privacy policy which is available at
https://europe.medtronic.com/xd-en/privacy-statement.html (EuropeanUnion), https://www.medtronic.com/us-en/privacy-statement.html (United States), https://asiapac.medtronic.com/xp-en/privacy-statement.html (Asia Pacific region), or https://latinoamerica.medtronic.com/xl-es/declaracion-de-privacidad.html (Latin America).
©2022 Medtronic. Medtronic and the Medtronic logo are trademarks of Medtronic. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. 1/2023